Fibrosis stage reference images

Similar documents
National Haemoglobinopathy Registry. Annual Report 2015/16. mdsas

National Haemoglobinopathy Registry. Annual Report 2017/18

National Peer Review Report: Sarcoma Cancer Services Report 2012/2013

PARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION. A03/S(HSS)/a Pancreas transplantation service (Adult)

NIHR Supporting collaboration in life sciences research

Funding research for the future

Why to biopsy? Indications for liver biopsy in common medical liver diseases- how are they changing?

The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033

AUGIS HPB cancer resection audit

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

The number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275

Clinical Research Facilities. Guide to using the NIHR identity

NHS Array Service. ACC Audit 2009

OPHTHALMIC PATHOLOGY

Sami Shousha Editor. Breast Pathology. Problematic Issues

Job planning checklists and diary. Specialty doctors and associate specialists

Pathology. Consortium of renal pathologist. Pathologists

National Training Course in Thyroid Ultrasound and FNAC

Histopathology National Quality Improvement Programme Data Report 2015 Edition 3 created July 2016

PBC/AIH variant/ overlap syndrome vs PBC with hepatitic features?

Pathology of Treated GI Neoplasia

14 January Dear Endometriosis Centre Lead

Molecular blood spot performance monitoring

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

out of hours donor frozen section

Dr Megan Rowley. CONSULTANT HAEMATOLOGIST - NHSBT and Imperial

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

ACCELERATING PROGRESS THROUGH COLLABORATION ACCELERATOR AWARD CASE STUDIES

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

pat hways Medtech innovation briefing Published: 20 September 2017 nice.org.uk/guidance/mib120

Transplant Activity in the UK

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

INTERIM REPORT ON KIDNEY TRANSPLANTATION

Nutrition and MND. Dr Chris McDermott

The number of patients on the active liver transplant list at 31 March 2017 was 530, a fall of 8% from 2016

THE DENTAL POSTCODE LOTTERY: AVERAGE COST OF CHECK-UPS VARY BY 44 ACROSS THE UK

Patient and Carer Network. Work Plan

CCLG National Febrile Neutropenia Audit Report 2015

Victoria YY Xu PGY-3 Internal Medicine University of Toronto. Supervisor: Dr. Camilla Wong

DILI PATHOLOGY. PHILIP KAYE November 2017 BSG Pathology Winter Meeting

Challenges in the Diagnosis of Steatohepatitis

Identifying distinguishing features of the MDC model within the five ACE projects

Dermatological content of U.K. undergraduate curricula in 2015: full report

Diabetes is a lifelong, chronic. Survey on the quality of diabetes care in prison settings across the UK. Keith Booles

DIRECTED WORKPLACE-BASED ASSESSMENTS BY STAGES OF TRAINING AND OPTIONAL PACKAGES

Development of a clinical assessment for dysarthria (N-DAT): The development & implementation of a new assessment tool and use of E3BP.

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME

Victoria YY Xu PGY-2 Internal Medicine University of Toronto. Supervisor: Dr. Camilla Wong

Information for Breast Patients having a Sentinel Node Biopsy

S ince the discovery of hepatitis C, there have been several

Clinical Oncology UK Workforce Report 2012 Faculty of Clinical Oncology

RESEARCH IN CARDIOLOGY Why, When, Where and How?

NHS BLOOD AND TRANSPLANT LIVER ADVISORY GROUP WAITING TIMES AND DEATHS ON THE LIST BY BLOOD GROUP SUMMARY

Self-assessment checklist

Specialist Fertility Treatment Local Criteria

AN INFORMATION GUIDE THE BRITISH SOCIETY FOR RESTORATIVE DENTISTRY

Approved Clinician frequently asked questions June 2017

Collaboration between CEQAS and UK NEQAS for Molecular Genetics Solid Tumour EQAs and variant interpretation

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

Activity Report July 2012 June 2013

Hepatitis C wi w t i h Ju J dy y W y W a y t a t t

Knowledge and awareness of type 1 diabetes among primary school initial teacher trainees

Chronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis

Session 1 - Innovation in Diagnosis and Intervention for Autism and Related Disorders

National Lung Cancer Audit Lung cancer consultant outcomes publication 2016 (for the 2013 audit period)

Membership Recruitment and Engagement Strategy

Aspects of quality in breast pathology. Andrew Lee Nottingham University Hospitals

National Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator

This report has been produced by Statistics and Clinical Audit, NHS Blood and Transplant.

COPD Bronchiectasis Overlap Syndrome.

COMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME

Inaugural UK IgG4-related disease Symposium. Royal College of Physicians, London

HEEM/NHS Trusts Relational Health Audit 2014

In response to an enquiry from the Scottish Clinical Biochemistry Managed Diagnostic Network

R e s e a r c h S t r a t e g y

OPAT DATA MANAGEMENT: AN OVERVIEW OF NORS & THE OPAT SERVICE DIRECTORY. BSAC OPAT REGIONAL WORKSHOP London 14 May 2018

Meeting the Future Challenge of Stroke

Patient Information Sheet Opportunistic Detection of Atrial Fibrillation in Ambulatory Blood Pressure Monitoring

TRANSPLANT ACTIVITY IN THE UK

Northumbria Healthcare NHS Foundation Trust. Breast Sentinel Lymph Node Biopsy. Issued by the Breast Team

MS Trust Comments on the ACD

Review of cellular pathology governance, breast reporting and immunohistochemistry at. Sherwood Forest Hospitals NHS Foundation Trust

PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)

Breast Screening Information and advice for patients

External Quality Assurance in Genetics Laboratories

ORGANISING COMMITTEE

Update on the National HPB Audit. Richard M Charnley Iain C Cameron

Patient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility

TRANSITIONS TO PALLIATIVE CARE FOR OLDER PEOPLE IN ACUTE HOSPITALS

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

Rigorous Bench Studies to Determine Sensitivity & Precision of Athelas Strip & Device. At-Home Usability and Interpretability Studies for Consumers

Translating MRS into clinical benefit for children with brain tumours

Activity Report April 2013 March 2014

Dudley End of Life and Palliative Care Strategy Implementation Plan 2017

OK to ask campaign: Summary report

Dialectical Behaviour Therapy (DBT) Information Leaflet

Lung Pathway Group Metrics. Stephen Scott Senior Cancer Information Analyst

Summary of Significant Changes. Policy

YORKSHIRE AND NORTH EAST ENGLAND

LCA Lung Clinical Forum. 21 st October 2014

Transcription:

Fibrosis stage reference images The following images are provided with the aim of improving inter-observer agreement in the assessment of fibrosis stage in liver biopsies, especially among non-specialist pathologists. They provide a bench mark of liver biopsy staging for routing diagnostic practice. They use a scale of none/early/bridging/late stage fibrosis. These stages are clinically important in patient management, and can be recognised in chronic liver disease of any or mixed aetiologies. The images are of the good sized biopsies stained by Sirius Red which had either complete agreement by 8 UK liver pathologists, or had a 4:4 split. The latter represent the threshold between adjacent stages. Use of these images improved agreement among both the specialist liver pathologists and among a group of generalist and trainee pathologists.

On behalf of: The UK Liver Pathology Group. Can the Inter-Observer Agreement of Reporting Fibrosis in Medical Liver Core Biopsies be Improved with the Use of Reference Images? A Study Comparing Liver Subspecialists and General Histopathologists. German, A.L. 1 ; Fleming, K.A. 2 ; Kaye, P.V. 3 ; Davies, S.E. 4 ; Goldin, R. 5 ; Hubscher, S.G. 6 ; Tiniakos, D. 7 ; McGregor, A. 8 ; Bellamy, C. 9 ; Wyatt, J.I. 1 1 Leeds Teaching Hospitals NHS Trust, Leeds; 2 Green Templeton College, Oxford University, Oxford; 3 Nottingham University Teaching Hospitals NHS Trust, Nottingham; 4 Cambridge University Hospitals NHS Foundation Trust, Cambridge; 5 Imperial College Healthcare NHS Trust, London; 6 University Hospitals Birmingham NHS Foundation Trust, Birmingham; 7 Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne; 8 The University Hospitals of Leicester NHS Trust, Leicester; 9 Edinburgh Royal Infirmary, Edinburgh. Example Reference Images None/early Early Introduction Liver biopsy plays an important part in assessing patients with a variety of liver diseases. At present, a number of different scoring systems are used by histopathologists to report the level of fibrosis in liver biopsies. The system used is dependent on the underlying pathology, and as such can become complex and confusing for pathologists, especially if reporting biopsies infrequently, or if of a mixed aetiology 1. There is also an inherent level of inter-observer variation between pathologists 2 and previous studies have provided Kappa scores for inter-observer agreement of between 0.5-0.9 1. This study was performed to assess if a set of reference images can improve the inter-observer agreement, in a simplified staging system of liver fibrosis, using four clinically relevant stages: None No evidence of fibrosis Early Any definite fibrosis (portal or sinusoidal) without bridging. Bridging Bridging fibrosis, without nodules Late Bridging fibrosis, and nodule formation These stages are non-numeric and independent of the type of chronic liver disease. Results A total of eight subspecialist liver pathologists, and ten general pathologists or trainees completed both phases of the study (eighteen overall). For the general pathologists, the raters were reporting between 10 - >80 biopsies per year. The results found a modest improvement in overall percentage agreement with the use of reference images from 67.79% to 70.08%, eliminated the spread over 3 different stages in phase 2, and an improved agreement across all four grades. The Fleiss Kappa and Krippendorff-α also confirm an overall improved agreement with the use of reference images. The Kappa score shows moderate agreement, and improved from 0.55 0.59 and the Krippendorffα from 0.55 0.57. For the subspecialist liver pathologists the results the percentage agreement improved from 65.35% to 68.84%, with the Kappa improving from 0.51 0.58, and Krippendorff-α from 0.51-0.54. For the general pathologists and trainees, the percentage agreement improved from 69.65 to 70.97, with the Kappa improving from 0.58 0.60, and Krippendorff-α from 0.57 0.58. 50 0.65 0.6 0.55 0.5 0.45 Early/Bridging Bridging Bridging/Late Late Fleiss Kappa Score with 95% Confidence Intervals Stage 1 Stage 2 Stage 1 Stage 2 Stage 1 Stage 2 Specialists = 8 Generalists = 10 All Reponders = 18 Method The study was initially completed by eight subspecialist liver pathologists in two phases. In phase one, the raters assessed the stage of liver fibrosis in 47 virtual slides stained with Sirius red, and a minimum biopsy length of 23mm, according to the four categories of none, early, bridging or late. The responses were then collated, allowing identification of those which had either complete agreement, or a 50:50 split across stages. These were then provided as reference images for agreed and threshold examples of fibrosis stage. The purpose of the threshold examples is to provide a benchmark that separates the stages, and not considered as additional categories. For phase two, a further 47 virtual slides were distributed, along with the reference images to use as a guide. The slides were hosted on the Leeds University Virtual Pathology website. General histopathology consultants who participated in the liver EQA scheme, and trainees who occasionally report liver pathology were then invited to complete both phases of the study, utilizing the same reference images for phase two. The results were analysed for all participants, and separately for the subspecialists and generalists, to assess if any improvement was applicable to both cohorts. We identified the percentage agreement along with the the Fleiss Kappa score and Krippendorffα for phase one and two. 0.65 0.6 0.55 0.5 0.45 40 30 20 10 Krippendorff-α with 95% Confidence intervals Stage 1 Stage 2 Stage 1 Stage 2 Stage 1 Stage 2 Specialists = 8 Generalists = 10 All Reponders = 18 0 Stage 1 Stage 2 Stage 1 Stage 2 Stage 1 Stage 2 Specialists = 8 Generalists = 10 All Responders = 18 Conclusions The staging of liver fibrosis has an inherent inter-observer variability. This study shows that the use of reference images when assessing the level of fibrosis, improves the level of percentage agreement across all categories, and eliminates the spread across three categories. This is seen in both subspecialist and general histopathologists Whilst recognising that disease specific fibrosis staging systems, such as Ishak and Kleiner et al, have an important role in research, they are found to be poorly reproducible in everyday routine reporting 2. We propose that the simpler 4-stage reporting, along with the use of the reference images, would improve the reproducibility and reliability of the score, amongst both generalist and specialist pathologists, which would provide our clinicians with a clinically and prognostically relevant result. The reference images would be available free online to provide an easy point of reference, and improve consistency in reporting. References 3 categories 2 categories (>1 participant different) 2 categories (All but one participant agree) 1. Goodman, Z.D. Grading and staging systems for inflammation and fibrosis in chronic liver disease. Journal of Hepatology; 47 (2007). 598-607. 2. Wyatt, J., Hubscher, S., Bellamy, C. Tissue pathways for liver biopsies for the investigation of medical disease and focal lesions. Royal College of Pathologists; March 2014. Accessed online.

None/early

None/early

None/early

Early

Early

Early

Early/bridging

Early/bridging

Bridging

Bridging

Bridging

Bridging/late

Bridging/late

Late

Late